Kasey Leger

5PUBLICATIONS
31CO-AUTHORS
Haematological tumoursRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 24, 2026
AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group.

|Mar 10, 2023
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma.

Christopher J Forlenza, Jaclyn Rosenzweig, Audrey Mauguen

|Feb 10, 2023
Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapy.

Brittany M Lee, Corinne Summers, Karen M Chisholm

|Dec 23, 2022
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.

Paul Harker-Murray, Christine Mauz-Körholz, Thierry Leblanc

|Mar 22, 2021
Lineage Switch in an Infant B-Lymphoblastic Leukemia With t(1;11)(p32;q23); KMT2A/EPS15, Following Blinatumomab Therapy.

Jing Du, Karen M Chisholm, Karen Tsuchiya

Pageof 1

Frequent Collaborators

1 joint publications

Christine Mauz-Körholz

1 joint publications

Maurizio Mascarin

1 joint publications

Auke Beishuizen

1 joint publications

Loredana Amoroso